Bank Pictet & Cie (Europe)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.7M | Sell |
140,228
-2,001
| -1% | -$264K | 0.35% | 54 |
|
|
2026
Q1 | $19.8M | Sell |
142,229
-9,664
| -6% | -$1.35M | 0.42% | 49 |
|
|
2025
Q4 | $18.6M | Buy |
151,893
+136,605
| +894% | +$16.6M | 0.37% | 52 |
|
|
2025
Q3 | $1.7M | Buy |
15,288
+12,752
| +503% | +$1.45M | 0.03% | 107 |
|
|
2025
Q2 | $281K | Buy |
+2,536
| New | +$270K | 0.01% | 180 |
|
|
2024
Q2 | – | Sell |
-13,025
| Closed | -$954K | – | 167 |
|
|
2024
Q1 | $954K | Hold |
13,025
| – | – | 0.02% | 110 |
|
|
2023
Q4 | $1.06M | Hold |
13,025
| – | – | 0.03% | 142 |
|
|
2023
Q3 | $976K | Hold |
13,025
| – | – | 0.03% | 137 |
|
|
2023
Q2 | $1M | Sell |
13,025
-2,050
| -14% | -$163K | 0.03% | 142 |
|
|
2023
Q1 | $1.25M | Sell |
15,075
-950
| -6% | -$78.7K | 0.05% | 102 |
|
|
2022
Q4 | $1.38M | Hold |
16,025
| – | – | 0.07% | 96 |
|
|
2022
Q3 | $989K | Buy |
16,025
+1,500
| +10% | +$94.6K | 0.05% | 103 |
|
|
2022
Q2 | $898K | Hold |
14,525
| – | – | 0.04% | 102 |
|
|
2022
Q1 | $864K | Buy |
14,525
+3,000
| +26% | +$192K | 0.03% | 107 |
|
|
2021
Q4 | $837K | Hold |
11,525
| – | – | 0.03% | 109 |
|
|
2021
Q3 | $805K | Hold |
11,525
| – | – | 0.03% | 110 |
|
|
2021
Q2 | $794K | Hold |
11,525
| – | – | 0.03% | 111 |
|
|
2021
Q1 | $745K | Hold |
11,525
| – | – | 0.03% | 110 |
|
|
2020
Q4 | $671K | Buy |
+11,525
| New | +$695K | 0.03% | 104 |
|
|
2020
Q2 | – | Sell |
-8,784
| Closed | -$657K | – | 139 |
|
|
2020
Q1 | $657K | Sell |
8,784
-30,449
| -78% | -$2.1M | 0.06% | 84 |
|
|
2019
Q4 | $2.55M | Sell |
39,233
-1,370
| -3% | -$89.2K | 0.38% | 54 |
|
|
2019
Q3 | $2.57M | Sell |
40,603
-1,200
| -3% | -$78.4K | 0.44% | 48 |
|
|
2019
Q2 | $2.82M | Buy |
41,803
+1,200
| +3% | +$78.9K | 0.49% | 43 |
|
|
2019
Q1 | $2.64M | Buy |
40,603
+2,829
| +7% | +$188K | 0.45% | 44 |
|
|
2018
Q4 | $2.36M | Buy |
37,774
+13,380
| +55% | +$935K | 0.48% | 42 |
|
|
2018
Q3 | $1.88M | Buy |
24,394
+985
| +4% | +$74.4K | 0.27% | 61 |
|
|
2018
Q2 | $1.66M | Sell |
23,409
-4,232
| -15% | -$299K | 0.26% | 62 |
|
|
2018
Q1 | $2.08M | Buy |
27,641
+4,727
| +21% | +$376K | 0.34% | 55 |
|
|
2017
Q4 | $1.64M | Sell |
22,914
-2,901
| -11% | -$220K | 0.23% | 62 |
|
|
2017
Q3 | $2.09M | Buy |
25,815
+6,102
| +31% | +$467K | 0.3% | 59 |
|
|
2017
Q2 | $1.4M | Buy |
19,713
+7,781
| +65% | +$518K | 0.2% | 76 |
|
|
2017
Q1 | $810K | Sell |
11,932
-493
| -4% | -$34.7K | 0.12% | 95 |
|
|
2016
Q4 | $890K | Buy |
12,425
+2,498
| +25% | +$186K | 0.15% | 86 |
|
|
2016
Q3 | $785K | Buy |
9,927
+362
| +4% | +$29.4K | 0.14% | 88 |
|
|
2016
Q2 | $798K | Hold |
9,565
| – | – | 0.17% | 79 |
|
|
2016
Q1 | $879K | Buy |
9,565
+993
| +12% | +$89.5K | 0.18% | 70 |
|
|
2015
Q4 | $867K | Sell |
8,572
-4,640
| -35% | -$483K | 0.17% | 77 |
|
|
2015
Q3 | $1.3M | Buy |
+13,212
| New | +$1.47M | 0.3% | 66 |
|
|
2015
Q2 | – | Sell |
-12,080
| Closed | -$1.19M | – | 117 |
|
|
2015
Q1 | $1.19M | Buy |
12,080
+2,100
| +21% | +$213K | 0.28% | 60 |
|
|
2014
Q4 | $941K | Sell |
9,980
-300
| -3% | -$31K | 0.24% | 66 |
|
|
2014
Q3 | $1.09M | Sell |
10,280
-1,790
| -15% | -$175K | 0.3% | 52 |
|
|
2014
Q2 | $1M | Buy |
12,070
+1,960
| +19% | +$153K | 0.31% | 53 |
|
|
2014
Q1 | $716K | Sell |
10,110
-650
| -6% | -$51K | 0.25% | 60 |
|
|
2013
Q4 | $809K | Buy |
+10,760
| New | +$749K | 0.32% | 45 |
|
Other funds holding GILD
N
Bank Pictet & Cie (Europe)'s GILD Position: Q2 2026 in Review
Bank Pictet & Cie (Europe) reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $264K and leaving 140,228 shares worth $17.7M. The position accounts for 0.35% of the portfolio, ranked #54.
Bank Pictet & Cie (Europe) first reported a position in GILD in Q4 2013 and has held it in 44 quarters since. The position peaked at $19.8M in Q1 2026. 1,619 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Bank Pictet & Cie (Europe) held 140,228 shares of Gilead Sciences worth $17.7M as of Q2 2026.
- Bank Pictet & Cie (Europe) sold 2,001 Gilead Sciences shares in Q2 2026, an estimated $264K.
- Gilead Sciences made up 0.35% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #54 holding.
- Bank Pictet & Cie (Europe) first reported a position in Gilead Sciences in Q4 2013 and has held it in 44 quarters since.
- Bank Pictet & Cie (Europe)'s Gilead Sciences position peaked at $19.8M in Q1 2026.
- 1,619 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.